EE200100634A - Adenosiini haaret inhibeeriva toimega asendatud fenüültsükloheksaankarboksüülhappeamiidid - Google Patents

Adenosiini haaret inhibeeriva toimega asendatud fenüültsükloheksaankarboksüülhappeamiidid

Info

Publication number
EE200100634A
EE200100634A EEP200100634A EEP200100634A EE200100634A EE 200100634 A EE200100634 A EE 200100634A EE P200100634 A EEP200100634 A EE P200100634A EE P200100634 A EEP200100634 A EE P200100634A EE 200100634 A EE200100634 A EE 200100634A
Authority
EE
Estonia
Prior art keywords
acid amides
inhibitory activity
adenosine uptake
uptake inhibitory
phenylcyclohexanecarboxylic acid
Prior art date
Application number
EEP200100634A
Other languages
English (en)
Inventor
Freund Wolf-Dietrich
Lensky Stephen
Nicholas M�ller Stephan
Paulsen Holger
Keldenich J�Rg
Horv�th Ervin
Schuhmacher Joachim
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of EE200100634A publication Critical patent/EE200100634A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200100634A 1999-05-29 2000-05-16 Adenosiini haaret inhibeeriva toimega asendatud fenüültsükloheksaankarboksüülhappeamiidid EE200100634A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19924818A DE19924818A1 (de) 1999-05-29 1999-05-29 Substituierte Phenylcyclohexancarbonsäureamide
PCT/EP2000/004417 WO2000073275A1 (de) 1999-05-29 2000-05-16 Substituierte phenylcyclohexancarbonsäureamide mit adenosinaufnahme-hemmender wirkung

Publications (1)

Publication Number Publication Date
EE200100634A true EE200100634A (et) 2003-02-17

Family

ID=7909712

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100634A EE200100634A (et) 1999-05-29 2000-05-16 Adenosiini haaret inhibeeriva toimega asendatud fenüültsükloheksaankarboksüülhappeamiidid

Country Status (36)

Country Link
US (2) US6716849B1 (et)
EP (1) EP1185516B1 (et)
JP (1) JP2003500475A (et)
KR (1) KR20020003397A (et)
CN (1) CN1200932C (et)
AR (1) AR024100A1 (et)
AT (1) ATE238997T1 (et)
AU (1) AU765752B2 (et)
BG (1) BG106107A (et)
BR (1) BR0011061A (et)
CA (1) CA2375186A1 (et)
CZ (1) CZ20014288A3 (et)
DE (2) DE19924818A1 (et)
DK (1) DK1185516T3 (et)
EE (1) EE200100634A (et)
ES (1) ES2197870T3 (et)
GT (1) GT200000083A (et)
HK (1) HK1048810A1 (et)
HN (1) HN2000000072A (et)
HR (1) HRP20010955A2 (et)
HU (1) HUP0201350A3 (et)
IL (1) IL146392A0 (et)
MA (1) MA25414A1 (et)
MX (1) MXPA01012241A (et)
MY (1) MY122576A (et)
NO (1) NO20015810L (et)
PE (1) PE20010167A1 (et)
PL (1) PL352101A1 (et)
PT (1) PT1185516E (et)
RU (1) RU2246490C9 (et)
SI (1) SI1185516T1 (et)
SK (1) SK17052001A3 (et)
SV (1) SV2004000087A (et)
UA (1) UA73126C2 (et)
WO (1) WO2000073275A1 (et)
ZA (1) ZA200109263B (et)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1834090B (zh) * 2005-03-18 2011-06-29 中国科学院上海药物研究所 苯并咪唑类化合物、其制备方法以及用途
BRPI0914788B1 (pt) * 2008-06-16 2020-04-07 Boehringer Ingelheim Int processo para produção de um produto intermediário de etexilato de dabigatran
US9550737B2 (en) 2012-06-11 2017-01-24 Ucb Biopharma Sprl TNF -α modulating benzimidazoles
CA3120941A1 (en) * 2018-11-25 2020-05-28 Tnt Medical Corporation Orally active prodrug of gemcitabine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685918B1 (fr) 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
DE4221009A1 (de) 1992-06-26 1994-01-05 Bayer Ag Imidazolyl-substituierte Cyclohexanderivate
EP0582164B1 (en) 1992-07-31 1998-12-23 Bristol-Myers Squibb Company Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles
DE4304455A1 (de) 1993-02-15 1994-08-18 Bayer Ag Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4401893A1 (de) 1994-01-24 1995-07-27 Bayer Ag Substituierte Arylharnstoffe
HRP960015B1 (en) 1995-02-01 2000-12-31 Bayer Ag Substituted indole derivatives
DE19503160A1 (de) 1995-02-01 1996-08-08 Bayer Ag Verwendung von Phenylcyclohexylcarbonsäureamiden

Also Published As

Publication number Publication date
CZ20014288A3 (cs) 2002-03-13
SI1185516T1 (en) 2003-10-31
HK1048810A1 (zh) 2003-04-17
PL352101A1 (en) 2003-07-28
MY122576A (en) 2006-04-29
WO2000073275A1 (de) 2000-12-07
CA2375186A1 (en) 2000-12-07
AU4405500A (en) 2000-12-18
AU765752B2 (en) 2003-09-25
EP1185516A1 (de) 2002-03-13
SV2004000087A (es) 2004-05-07
GT200000083A (es) 2001-11-17
DE50001982D1 (de) 2003-06-05
MXPA01012241A (es) 2002-08-12
SK17052001A3 (sk) 2002-06-04
CN1200932C (zh) 2005-05-11
NO20015810D0 (no) 2001-11-28
HUP0201350A2 (en) 2002-08-28
EP1185516B1 (de) 2003-05-02
US20040186106A1 (en) 2004-09-23
MA25414A1 (fr) 2002-04-01
PE20010167A1 (es) 2001-04-25
BR0011061A (pt) 2002-03-05
UA73126C2 (en) 2005-06-15
HRP20010955A2 (en) 2003-08-31
AR024100A1 (es) 2002-09-04
RU2246490C9 (ru) 2005-09-20
ATE238997T1 (de) 2003-05-15
IL146392A0 (en) 2002-07-25
KR20020003397A (ko) 2002-01-12
PT1185516E (pt) 2003-09-30
DE19924818A1 (de) 2000-11-30
ES2197870T3 (es) 2004-01-16
RU2246490C2 (ru) 2005-02-20
JP2003500475A (ja) 2003-01-07
BG106107A (bg) 2002-05-31
US6716849B1 (en) 2004-04-06
CN1365356A (zh) 2002-08-21
ZA200109263B (en) 2003-01-29
DK1185516T3 (da) 2003-08-11
NO20015810L (no) 2002-01-25
HN2000000072A (es) 2001-02-02
HUP0201350A3 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
IS5635A (is) Indólýl-3-glýoxýlsýru afleiður með virkni gegn æxlum
DE60018357D1 (de) Dachlastträger
ATE419231T1 (de) Mono-substituierte 3-propyl-gamma- aminobuttersäure
DE69901673T2 (de) Befestigungsmittel
DE59909387D1 (de) Elektrokardiogramm-Anordnung
NO993262D0 (no) Avl°pssystem
PT1074551E (pt) Fenilpirazois com actividade herbicida
PT1206476E (pt) 9a-azalidos com actividade antibacteriana
DE60042276D1 (de) Stromloses plattierungsverfahren
EE200100634A (et) Adenosiini haaret inhibeeriva toimega asendatud fenüültsükloheksaankarboksüülhappeamiidid
ATA33399A (de) Gattersäge
DK1187812T3 (da) Substituerede phenylcyclohexancarboxylsyreamider og deres anvendelse som adenosinoptagelses-inhibitorer
DE60011095D1 (de) Bügelanordnung
DE29900521U1 (de) Befestigungselement
DE59806454D1 (de) Baugruppenträger
DE29813334U1 (de) Freizeitobjekt zur aktiven körperlichen Betätigung
ITMI990214V0 (it) Struttura perfezionata di termomanometro
DE29805199U1 (de) Längsabsteller
DE29905543U1 (de) Befestigungselement
FI990662A0 (fi) Palkki
FI991375A0 (fi) Jännitetty liittopalkki
UA3099S (uk) Стійка під штанги
DK1090019T3 (da) Adenosinderivater
FI4267U1 (fi) Teline
SE9903640D0 (sv) Cykelställ